We use cookies for a better user experience. Read our Privacy Policy

I Agree

Deep Brain Stimulation Devices Market

Deep Brain Stimulation Devices Market for Parkinson’s Disease (Product Type: Single-Channel Deep Brain Stimulator and Dual-Channel Deep Brain Stimulator; and End-user: Hospitals, Ambulatory Surgical Centers, Neurological Clinics, and Others) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2021-2028

Deep Brain Stimulation Devices Market for Parkinson’s Disease Outlook 2028

  • The global deep brain stimulation devices market for Parkinson’s disease was valued at US$ 0.85 Bn in 2020
  • It is estimated to expand at a CAGR of 5.1% from 2021 to 2028
  • The global deep brain stimulation devices market for Parkinson’s disease is expected to surpass the value of US$ 1.2 Bn by the end of 2028

Analysts’ Viewpoint on Deep Brain Stimulation Devices Market for Parkinson’s Disease Scenario

Telehealth and eHealth apps are gaining popularity during the ongoing coronavirus pandemic to routinely monitor PD patients. Favorable reimbursement policies across healthcare facilities worldwide are contributing to the expansion of the deep brain stimulation devices market for Parkinson’s disease. However, there is a need for technological advancements in implantable pulse generators of DBS systems. Hence, companies in the deep brain stimulation devices market for Parkinson’s disease should increase R&D for maximizing battery longevity, combined with patient-related elements such as reliability of IPG recharging or consistency of nightly device shutoff. Device-specific features such as parameter delivery, choice of lead configuration, implantation location, and careful selection of electrode materials to minimize impedance mismatch are crucial for med-tech companies to gain a competitive edge in the global deep brain stimulation devices market for Parkinson’s disease.

Commercialization of Portable, Affordable, and Effective DBS Devices

Companies operating in the deep brain stimulation devices market for Parkinson's disease are increasing efforts to commercialize devices in the global market. Products of other companies active in the market for DBS (deep brain stimulation) are not yet commercially available, as these are still under clinical trial. Companies are keen on introducing innovative products that are easy to use for physicians as well as patients. These companies aim to make the devices more portable, affordable, efficient, and effective.

Request a sample to get extensive insights into the Deep Brain Stimulation Devices Market

Telehealth Helps Address Challenges of PD Patients amid Coronavirus Pandemic

The containment measures taken by various government authorities during the ongoing coronavirus pandemic has caused the interruption of neurological activities for outpatient clinics. Vulnerable patients suffering from Parkinson's disease (PD) and dystonic patients with deep brain stimulation may have an increased risk of chronic stress related to social restriction measures and show a potential worsening of motor & psychiatric symptoms. In such cases, telehealth and eHealth mobile apps are playing a key role to address the symptoms of PD patients. Moreover, med-tech companies are increasing efforts to maintain robust supply of DBS devices to prevent interruptions in medical treatment of patients.

To understand how our report can bring difference to your business strategy, Ask for a brochure

DBS Surgical Therapy V/S Drug Therapy: Which is Better?

According to analysts at Transparency Market Research (TMR), the growing popularity of minimally invasive procedures is estimated to drive the demand for deep brain stimulation devices for Parkinson's disease. The deep brain stimulation surgical therapy is currently gaining traction and has risen to a popular therapy of choice when the Parkinson's disease in the patient is at its advanced stage.

Since the drug therapy is associated with certain adverse events, doctors, and patients are increasingly opting for deep brain stimulation surgical therapies. In addition, the efficacy of drug therapy cannot be determined in terms of certainty. This is another factor, which is driving doctors and patients to choose the deep brain stimulation surgical therapy over drug therapy.

Stuck in a neck-to-neck competition with other brands? Request a custom report on Medical Robotics Market

Popularity of DBS Devices for Surgical Procedures in America Benefits Med-tech Companies

The global deep brain stimulation devices market for Parkinson’s disease is positioned to register a modest CAGR throughout the forecast period. North America is predicted to dictate the global market during the forecast period, accounting for more than 30% to 40% share by 2028. The market in the region is anticipated to reach a significant value growth by 2028.

North America's largest market share can be attributed to increase in a number of patients undergoing surgical therapy that utilizes DBS devices for treating Parkinson’s disease and surge in geriatric population. Additionally, favorable government reimbursement policies and risk of side effects related to medication treatments are expected to boost the growth of the deep brain stimulation devices market for Parkinson’s disease in the region.

Increase in Number of Medical Practitioners Adopting Deep Brain Stimulation Devices

Burgeoning growth of the geriatric population and rise in demand for minimally invasive surgical techniques are triggering the growth of the deep brain stimulation devices market for Parkinson’s disease. Moreover, change in preferences of patients and healthcare professionals to adopt surgical DBS devices over drug therapy is projected to fuel the expansion of the global deep brain stimulation devices market for Parkinson’s disease in the upcoming decade. This is due to considerable side effects and loss of effectiveness of drugs & other therapeutics. This is anticipated to drive the market for DBS devices over the next few years.

Risk of Infection with IPG Affects Acceptance for DBS Devices

The global market for DBS devices is predicted to register favorable Y-o-Y growth throughout the assessment period. However, there are a few factors, which are anticipated to go against the growth of the market. One of the key factors hampering the growth of this market is the associated risks involved with deep brain stimulation procedures.

For instance, implantable pulse generator (IPG) is the core power supply and programmable element in DBS systems. However, the risk of infections due to IPG is expected to limit the use of deep brain stimulation devices for Parkinson's disease. Hence, healthcare stakeholders should increase awareness about antibiotic impregnation and co-administration & other surgical considerations during IPG implantation such as the use of tack-up sutures & smaller profile devices.

Deep Brain Stimulation Devices Market for Parkinson’s Disease: Overview

  • Parkinson’s disease is one of the most common chronic and progressive neurological disorders, which is characterized by postural instability, bradykinesia, akinesia, and tremors due to loss of dopamine producing neurons in substantia nigra of the mid-brain

Increase in Government Initiatives: Key Driver

  • Increase in number of neurological disorders such ischemic stroke, Alzheimer’s disease, tremors, trauma, and Parkinson’s disease (PD) are primary factors responsible for the growth of the global deep brain stimulation devices market
  • Additionally, surge in the geriatric population and rise in demand for minimally invasive surgical techniques boost the growth of the global market. Moreover, change in preferences of patients and healthcare professionals to adopt surgical DBS devices over drug therapy is projected to fuel the growth of the global deep brain stimulation devices market in the near future. This can be attributed to considerable number of side effects and loss of effectiveness of drug and other therapies.

North America to Dominate Deep Brain Stimulation Devices Market for Parkinson’s Disease

  • Based on product type, the global deep brain stimulation devices market for Parkinson’s disease has been segmented into single-channel deep brain stimulator, and dual-channel deep brain stimulator
  • In terms of end-user, the global deep brain stimulation devices market for Parkinson’s disease has been classified into hospitals, ambulatory surgical centers, neurological clinics, and others
  • In terms of region, the global deep brain stimulation devices market for Parkinson’s disease has been segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa
  • North America is projected to dominate the global market during the forecast period, accounting for 38.60% share by 2028. The market in the region is anticipated to reach US$ 0.48 Bn by 2028.
  • North America's largest market share can be attributed to increase in the number of patients undergoing surgical therapy that utilizes DBS devices for treating Parkinson’s disease and surge in the geriatric population. Additionally, favorable government reimbursement policies and risk of side effects related to medication treatments are expected to boost the growth of the market in North America.
  • Small market share of Asia Pacific, Latin America, and Middle East & Africa can be ascribed to lack of awareness, lack of favorable government support & other insurance policies, and high cost of these devices

Major Players

  • Major players operating in the global deep brain stimulation devices market are Medtronic, Inc., St. Jude Medical, Inc. and Boston Scientific Corporation. These companies have commercialized several significant DBS devices in the global market such as Libra, Activa, and Vercise. Other companies that are prominently active in the market are Aleva Neurotherapeutics SA, Adaptive Neuromodulation GmbH (ANM), NeuroSigma, Inc., and NeuroPace, Inc. DBS products of these players are not yet commercially available in the market, as these are still under clinical trials.
  • Companies focus on introducing innovative products that are easy to use for physicians as well as patients. These companies aim to make the devices more portable, affordable, efficient, and effective.
  • Each of these players has been profiled in the deep brain stimulation devices market for Parkinson’s disease report based on parameters such as company overview, financial overview, business strategies, application portfolio, business segments, and recent developments

Deep Brain Stimulation Devices Market for Parkinson’s Disease Snapshot

Attribute

Detail

Market Size Value in 2020 (Base Year)

US$ 0.85 Bn

Market Forecast Value in 2028

US$ 1.2 Bn

Growth Rate (CAGR)

5.1%

Forecast Period

2017–2028

Quantitative Units

US$ Mn for Value

Market Analysis

It includes cross segment analysis at regional level. Moreover, qualitative analysis includes drivers, restraints, opportunities, key trends, pricing analysis, and parent industry overview.

Format

Electronic (PDF)

Market Segmentation

  • Product Type
    • Single-Channel Deep Brain Stimulator
    • Dual-Channel Deep Brain Stimulator
  • End-user
    • Hospitals
    • Ambulatory Surgical Centers
    • Neurological Clinics
    • Others

Regions Covered

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa

Countries Covered

  • U.S.
  • Canada
  • Germany
  • U.K.
  • France
  • Italy
  • Spain
  • Rest of Europe
  • China
  • India
  • Japan
  • Australia & New Zealand
  • Rest of Asia Pacific
  • Brazil
  • Mexico
  • Rest of Latin America
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Customization Scope

Available upon request

Pricing

Available upon request

Deep Brain Stimulation Devices Market for Parkinson’s Disease – Segmentation

TMR’s study on the global deep brain stimulation devices market for Parkinson’s disease includes information divided into three segments: product type, end-user, and region. Changing industry trends and other market dynamics associated with these segments of the global deep brain stimulation devices market for Parkinson’s disease are discussed in detail.

Product Type

  • Single-channel Deep Brain Stimulator
  • Dual-channel Deep Brain Stimulator

End-user

  • Hospitals
  • Ambulatory Surgical Centers
  • Neurological Clinics
  • Others

Region

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa
Deep Brain Stimulation Devices Market

Interested in this report?
Get a FREE Brochure now!

Get Free Brochure

*Get Brochure Report (PDF) sent to your email within minutes

Frequently Asked Questions

What is the total market worth of deep brain stimulation devices market?

Deep brain stimulation devices market for Parkinson’s disease is expected to surpass the value of US$ 1.2 Bn by the end of 2028

What is the anticipated CAGR of the deep brain stimulation devices market in the forecast period?

Deep brain stimulation devices market is estimated to expand at a CAGR of 5.1% from 2021 to 2028

What are the key driving factors for the growth of the deep brain stimulation devices market?

Deep brain stimulation devices market is driven by increase in the geriatric population and rise in demand for minimally invasive surgical techniques

Which region is expected to project the highest market share in the global deep brain stimulation devices market?

North America is projected to dominate the global deep brain stimulation devices market during the forecast period

Who are the key players in the global deep brain stimulation devices market?

Key players operating in the global deep brain stimulation devices market include Medtronic, Inc., St. Jude Medical, Inc., and Boston Scientific Corporation

1. Preface

    1.1. Market Definition and Scope

    1.2. Market Segmentation

    1.3. Key Research Objectives

    1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Global Deep Brain Stimulation Devices Market for Parkinson’s Disease

4. Market Overview

    4.1. Introduction

        4.1.1. Product Definition

        4.1.2. Industry Evolution / Developments

    4.2. Overview

    4.3. Market Dynamics

        4.3.1. Drivers

        4.3.2. Restraints

        4.3.3. Opportunities

    4.4. Global Deep Brain Stimulation Devices Market for Parkinson’s Disease Analysis and Forecast, 2017–2028

        4.4.1. Market Revenue Projections (US$ Mn)

5. Key Insights

    5.1. Disease Prevalence & Incidence Rate globally with key countries

    5.2. COVID-19 Pandemic Impact on Industry (value chain and short / mid / long term impact)

6. Global Deep Brain Stimulation Devices Market for Parkinson’s Disease Analysis and Forecast, by Product Type

    6.1. Key Findings

    6.2. Market Value Forecast, by Product Type

        6.2.1. Single-Channel Deep Brain Stimulator

        6.2.2. Dual-Channel Deep Brain Stimulator

    6.3. Market Attractiveness Analysis, by Product Type

7. Global Deep Brain Stimulation Devices Market for Parkinson’s Disease Analysis and Forecast, by End-user

    7.1. Key Findings

    7.2. Market Value Forecast, by End-user

        7.2.1. Hospitals

        7.2.2. Ambulatory Surgical Centers

        7.2.3. Neurological Clinics

        7.2.4. Others

    7.3. Market Attractiveness Analysis, by End-user

8. Global Deep Brain Stimulation Devices Market for Parkinson’s Disease Analysis and Forecast, by Region

    8.1. Key Findings

    8.2. Market Value Forecast, by Region

        8.2.1. North America

        8.2.2. Europe

        8.2.3. Asia Pacific

        8.2.4. Latin America

        8.2.5. Middle East & Africa

    8.3. Market Attractiveness Analysis, by Country/Region

9. North America Deep Brain Stimulation Devices Market for Parkinson’s Disease Analysis and Forecast

    9.1. Introduction

        9.1.1. Key Findings

    9.2. Market Value Forecast, by Product Type, 2017–2028

        9.2.1. Single-Channel Deep Brain Stimulator

        9.2.2. Dual-Channel Deep Brain Stimulator

    9.3. Market Attractiveness Analysis, by Product Type

    9.4. Market Value Forecast, by End-user, 2017–2028

    9.5. Market Value Forecast, by End-user

        9.5.1. Hospitals

        9.5.2. Ambulatory Surgical Centers

        9.5.3. Neurological Clinics

        9.5.4. Others

    9.6. Market Attractiveness Analysis, by End-user

    9.7. Market Value Forecast, by Country/Sub-region, 2017–2028

        9.7.1. U.S.

        9.7.2. Canada

    9.8. Market Attractiveness Analysis

        9.8.1. By Product Type

        9.8.2. By End-user

        9.8.3. By Country/Sub-region

10. Europe Deep Brain Stimulation Devices Market for Parkinson’s Disease Analysis and Forecast

    10.1. Introduction

        10.1.1. Key Findings

    10.2. Market Value Forecast, by Product Type, 2017–2028

        10.2.1. Single-Channel Deep Brain Stimulator

        10.2.2. Dual-Channel Deep Brain Stimulator

    10.3. Market Attractiveness Analysis, by Product Type

    10.4. Market Value Forecast, by End-user, 2017–2028

    10.5. Market Value Forecast, by End-user

        10.5.1. Hospitals

        10.5.2. Ambulatory Surgical Centers

        10.5.3. Neurological Clinics

        10.5.4. Others

    10.6. Market Attractiveness Analysis, by End-user

    10.7. Market Value Forecast, by Country/Sub-region, 2017–2028

        10.7.1. Germany

        10.7.2. U.K.

        10.7.3. France

        10.7.4. Spain

        10.7.5. Italy

        10.7.6. Rest of Europe

    10.8. Market Attractiveness Analysis

        10.8.1. By Product Type

        10.8.2. By End-user

        10.8.3. By Country/Sub-region

11. Asia Pacific Deep Brain Stimulation Devices Market for Parkinson’s Disease Analysis and Forecast

    11.1. Introduction

        11.1.1. Key Findings

    11.2. Market Value Forecast, by Product Type, 2017–2028

        11.2.1. Single-Channel Deep Brain Stimulator

        11.2.2. Dual-Channel Deep Brain Stimulator

    11.3. Market Attractiveness Analysis, by Product Type

    11.4. Market Value Forecast, by End-user, 2017–2028

    11.5. Market Value Forecast, by End-user

        11.5.1. Hospitals

        11.5.2. Ambulatory Surgical Centers

        11.5.3. Neurological Clinics

        11.5.4. Others

    11.6. Market Attractiveness Analysis, by End-user

    11.7. Market Value Forecast, by Country/Sub-region, 2017–2028

        11.7.1. China

        11.7.2. Japan

        11.7.3. India

        11.7.4. Australia & New Zealand

        11.7.5. Rest of Asia Pacific

    11.8. Market Attractiveness Analysis

        11.8.1. By Product

        11.8.2. By Application

        11.8.3. By Country/Sub-region

12. Latin America Deep Brain Stimulation Devices Market for Parkinson’s Disease Analysis and Forecast

    12.1. Introduction

        12.1.1. Key Findings

    12.2. Market Value Forecast, by Product Type, 2017–2028

        12.2.1. Single-Channel Deep Brain Stimulator

        12.2.2. Dual-Channel Deep Brain Stimulator

    12.3. Market Attractiveness Analysis, by Product Type

    12.4. Market Value Forecast, by End-user, 2017–2028

    12.5. Market Value Forecast, by End-user

        12.5.1. Hospitals

        12.5.2. Ambulatory Surgical Centers

        12.5.3. Neurological Clinics

        12.5.4. Others

    12.6. Market Attractiveness Analysis, by End-user

    12.7. Market Value Forecast, by Country/Sub-region, 2017–2028

        12.7.1. Brazil

        12.7.2. Mexico

        12.7.3. Rest of Latin America

    12.8. Market Attractiveness Analysis

        12.8.1. By Product

        12.8.2. By Application

        12.8.3. By Country/Sub-region

13. Middle East & Africa Deep Brain Stimulation Devices Market for Parkinson’s Disease Analysis and Forecast

    13.1. Introduction

        13.1.1. Key Findings

    13.2. Market Value Forecast, by Product Type, 2017–2028

        13.2.1. Single-Channel Deep Brain Stimulator

        13.2.2. Dual-Channel Deep Brain Stimulator

    13.3. Market Attractiveness Analysis, by Product Type

    13.4. Market Value Forecast, by End-user, 2017–2028

    13.5. Market Value Forecast, by End-user

        13.5.1. Hospitals

        13.5.2. Ambulatory Surgical Centers

        13.5.3. Neurological Clinics

        13.5.4. Others

    13.6. Market Attractiveness Analysis, by End-user

    13.7. Market Value Forecast, by Country/Sub-region, 2017–2028

        13.7.1. GCC Countries

        13.7.2. South Africa

        13.7.3. Rest of Middle East & Africa

    13.8. Market Attractiveness Analysis

        13.8.1. By Product

        13.8.2. By Application

        13.8.3. By Country/Sub-region

14. Competition Landscape

    14.1. Market Player - Competition Matrix (by tier and size of companies)

    14.2. Market Share Analysis, by Company, 2020

    14.3. Company Profiles

        14.3.1. Aleva Neurotherapeutics SA

            14.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)

            14.3.1.2. Product Portfolio

            14.3.1.3. Financial Overview

            14.3.1.4. Strategic Overview

            14.3.1.5. SWOT Analysis

        14.3.2. Boston Scientific Corporation

            14.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)

            14.3.2.2. Product Portfolio

            14.3.2.3. Financial Overview

            14.3.2.4. SWOT Analysis

            14.3.2.5. Strategic Overview

        14.3.3. Medtronic, Inc.

            14.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)

            14.3.3.2. Product Portfolio

            14.3.3.3. Financial Overview

            14.3.3.4. SWOT Analysis

            14.3.3.5. Strategic Overview

        14.3.4. Medtronic

            14.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)

            14.3.4.2. Product Portfolio

            14.3.4.3. Financial Overview

            14.3.4.4. SWOT Analysis

            14.3.4.5. Strategic Overview

List of Tables

TABLE 1: Market Snapshot: Global Deep Brain Stimulation Devices Market for Parkinson’s Disease

TABLE 2: Relationship Between Age and the Occurrence of Parkinson’s Disease

TABLE 3: Deep Brain Stimulation Device’s U.S. FDA approval for Various Neurological Disorders

TABLE 4: Global Prevalence of Parkinson’s Disease, by Geography, 2017–2028 (Number of Patients)

TABLE 5: Global Number of Patients with Parkinson’s Disease Treated with Deep Brain Stimulation Devices, by Geography, 2017–2028

TABLE 6: Global Deep Brain Stimulation Devices for Parkinson’s Disease Market Revenue (US$ Mn), by Region, 2017–2028

TABLE 7: North America Prevalence of Parkinson’s Disease, by Country, 2017–2028 (Number of Patients)

TABLE 8: North America Number of Patients with Parkinson’s Disease Treated with Deep Brain Stimulation Devices, by Country, 2017–2028

TABLE 9: North America Deep Brain Stimulation Devices for Parkinson’s Disease Market Revenue (US$ Mn), by Country, 2017–2028

TABLE 10: Europe Prevalence of Parkinson’s Disease, by Country, 2017–2028 (Number of Patients)

TABLE 11: Europe Number of Patients with Parkinson’s Disease Treated with Deep Brain Stimulation Devices, by Country, 2017–2028

TABLE 12: Europe Deep Brain Stimulation Devices for Parkinson’s Disease Market Revenue (US$ Mn), by Country, 2017–2028

TABLE 13: Asia Pacific Prevalence of Parkinson’s Disease, by Country, 2017–2028 (Number of Patients)

TABLE 14: Asia Pacific Number of Patients with Parkinson’s Disease Treated with Deep Brain Stimulation Devices, by Country, 2017–2028

TABLE 15: Asia Pacific Deep Brain Stimulation Devices for Parkinson’s Disease Market Revenue (US$ Mn), by Country, 2017–2028

TABLE 16: Latin America Prevalence of Parkinson’s Disease, by Country, 2017–2028 (Number of Patients)

TABLE 17: Latin America Number of Patients with Parkinson’s Disease Treated with Deep Brain Stimulation Devices, by Country, 2017–2028

TABLE 18: Latin America Deep Brain Stimulation Devices for Parkinson’s Disease Market Revenue (US$ Mn), by Country, 2017–2028

TABLE 19: Middle East & Africa Prevalence of Parkinson’s Disease, by Country, 2017–2028 (Number of Patients)

TABLE 20: Middle East & Africa Number of Patients with Parkinson’s Disease Treated with Deep Brain Stimulation Devices, by Country, 2017–2028

TABLE 21: Middle East & Africa Deep Brain Stimulation Devices for Parkinson’s Disease Market Revenue (US$ Mn), by Country, 2017–2028

List of Figures

Figure 1: Deep Brain Stimulation Devices for Parkinson’s Disease: Market Segmentation

Figure 2: Global DBS Devices Market for Parkinson’s Disease (US$ Mn), by Region, 2020

Figure 3: Comparative Analysis: Global Deep Brain Stimulation Devices Market for Parkinson’s Disease (Value %), by Geography, 2020 & 2028

Figure 4: Porter’s Five Forces Analysis: Global Deep Brain Stimulation Devices Market for Parkinson’s Disease

Figure 5: Market Attractiveness Analysis: Global Deep Brain Stimulation Devices Market for Parkinson’s Disease

Figure 6: Market Share by Key Players: Global Deep Brain Stimulation Devices Market for Parkinson’s disease, 2020 (Value %) , by Geography, 2020

Figure 7: United States Deep Brain Stimulation Devices Market for Parkinson’s Disease Revenue (US$ Mn), 2017–2028

Figure 8: Canada Deep Brain Stimulation Devices Market for Parkinson’s Disease Revenue (US$ Mn), 2017–2028

Figure 9: Germany Deep Brain Stimulation Devices Market for Parkinson’s Disease Revenue (US$ Mn), 2017–2028

Figure 10: Italy Deep Brain Stimulation Devices for Parkinson’s Disease Market Revenue (US$ Mn), 2017–2028

Figure 11: Spain Deep Brain Stimulation Devices for Parkinson’s Disease Market Revenue (US$ Mn), 2017–2028

Figure 12: United Kingdom Deep Brain Stimulation Devices for Parkinson’s Disease Market Revenue (US$ Mn), 2017–2028

Figure 13: France Deep Brain Stimulation Devices for Parkinson’s Disease Market Revenue (US$ Mn), 2017–2028

Figure 14: RoE Deep Brain Stimulation Devices for Parkinson’s Disease Market Revenue (US$ Mn), 2017–2028

Figure 15: Australia Deep Brain Stimulation Devices for Parkinson’s Disease Market Revenue (US$ Mn), 2017–2028

Figure 16: China Deep Brain Stimulation Devices for Parkinson’s Disease Market Revenue (US$ Mn), 2017–2028

Figure 17: India Deep Brain Stimulation Devices for Parkinson’s Disease Market Revenue (US$ Mn), 2017–2028

Figure 18: New Zealand Deep Brain Stimulation Devices for Parkinson’s Disease Market Revenue (US$ Mn), 2017–2028

Figure 19: Japan Deep Brain Stimulation Devices for Parkinson’s Disease Market Revenue (US$ Mn), 2017–2028

Figure 20: Rest of APAC Deep Brain Stimulation Devices for Parkinson’s Disease Market Revenue (US$ Mn), 2017–2028

Figure 21: Brazil Deep Brain Stimulation Devices for Parkinson’s Disease Market Revenue (US$ Mn), 2017–2028

Figure 22: Mexico Deep Brain Stimulation Devices for Parkinson’s Disease Market Revenue (US$ Mn), 2017–2028

Figure 23: Latin America Deep Brain Stimulation Devices for Parkinson’s Disease Market Revenue (US$ Mn), 2017–2028

Figure 24: Middle East & Africa Deep Brain Stimulation Devices for Parkinson’s Disease Market Revenue (US$ Mn), 2017–2028

Transparency Market Research Plus
  • We offer 100% free customisation with our Enterprise License!!
  • Get a free copy if the report you purchased is updated within 90 days
  • Regardless from where you have purchased the report, you can request an updated version of the report from us.

Complete the form below and we'll get back to you shortly.

994

Your personal details are safe with us. Privacy Policy*

Copyright © Transparency Market Research, Inc. All Rights reserved